|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2005-12-13
|
|
pubmed:abstractText |
The annual relapse rate has been commonly used as a primary efficacy endpoint in phase III multiple sclerosis (MS) clinical trials. The aim of this study was to determine the relative contribution of different possible prognostic factors available at baseline to the on-study relapse rate in MS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1526-632X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
13
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1769-73
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16344520-Age Factors,
pubmed-meshheading:16344520-Age of Onset,
pubmed-meshheading:16344520-Causality,
pubmed-meshheading:16344520-Central Nervous System,
pubmed-meshheading:16344520-Clinical Trials as Topic,
pubmed-meshheading:16344520-Disability Evaluation,
pubmed-meshheading:16344520-Female,
pubmed-meshheading:16344520-Humans,
pubmed-meshheading:16344520-Magnetic Resonance Imaging,
pubmed-meshheading:16344520-Male,
pubmed-meshheading:16344520-Models, Statistical,
pubmed-meshheading:16344520-Multiple Sclerosis,
pubmed-meshheading:16344520-Multiple Sclerosis, Chronic Progressive,
pubmed-meshheading:16344520-Multiple Sclerosis, Relapsing-Remitting,
pubmed-meshheading:16344520-Predictive Value of Tests,
pubmed-meshheading:16344520-Prognosis,
pubmed-meshheading:16344520-Recurrence,
pubmed-meshheading:16344520-Regression Analysis,
pubmed-meshheading:16344520-Sex Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Predictors of relapse rate in MS clinical trials.
|
|
pubmed:affiliation |
Sylvia Lawry Centre for Multiple Sclerosis Research, Munich, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
